ADC Therapeutics SA Investments In Joint Ventures Accounted For Using Equity Method
ADC Therapeutics SA (ADCT) had Investments In Joint Ventures Accounted For Using Equity Method of $26.99 million as of 2023-09-30, per its 6-K filed 2023-11-07.
Discontinued › Notes
ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod · last filed 2023-11-07
- 2023-09-30: Investments In Joint Ventures Accounted For Using Equity Method $26.99M.
- 2023-06-30: Investments In Joint Ventures Accounted For Using Equity Method $28.32M.
- 2023-03-31: Investments In Joint Ventures Accounted For Using Equity Method $29.53M.
- 2022-12-31: Investments In Joint Ventures Accounted For Using Equity Method $31.15M.
| Period end | Investments In Joint Ventures Accounted For Using Equity Method |
|---|---|
| 2023-09-30 | $26.99M 6-K · filed 2023-11-07 |
| 2023-06-30 | $28.32M 6-K · filed 2023-08-08 |
| 2023-03-31 | $29.53M 6-K · filed 2023-05-09 |
| 2022-12-31 | $31.15M 6-K · filed 2023-11-07 |
| 2022-09-30 | $34.69M 6-K · filed 2022-11-08 |
| 2022-06-30 | $36.82M 6-K · filed 2022-08-09 |
| 2022-03-31 | $38.73M 6-K · filed 2022-05-09 |
| 2021-12-31 | $41.24M 20-F · filed 2023-03-15 |
| 2021-09-30 | $44.00M 6-K · filed 2021-11-02 |
| 2021-06-30 | $46.21M 6-K · filed 2021-08-03 |
| 2021-03-31 | $47.38M 6-K · filed 2021-05-06 |
| 2020-12-31 | $47.91M 20-F · filed 2022-03-17 |
| 2019-12-31 | $0.00 20-F · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |